Oren Beske

Title: Oren Beske: Innovator in Cytokine Engineering

Introduction

Oren Beske is a notable inventor based in Aromas, California. He has made significant contributions to the field of cytokine engineering, particularly through his innovative patent related to interleukin-21 (IL-21) cytokines. His work has the potential to impact various medical treatments and therapies.

Latest Patents

Oren Beske holds a patent titled "Engineered human IL-21 cytokines and methods for using the same." This patent describes orthogonal IL-21 receptors and orthogonal IL-21 cytokines. The IL-21 receptor-cytokine pairs include an orthogonal interleukin-21 receptor α chain, known as 'ortho-IL-21Rα,' which has impaired binding to native interleukin-21 cytokine. Additionally, the orthogonal IL-21 cytokine, referred to as “ortho-IL-21,” has impaired binding to native IL-21Rα. The ortho-IL-21Rα binds specifically to the ortho-IL-21, allowing for the activation of IL-21 signaling. His patent also describes cells engineered to express these orthogonal IL-21 receptors and methods for using such cells in the treatment of various diseases and disorders.

Career Highlights

Oren Beske is associated with Neptune Biosciences LLC, where he continues to advance his research and development in cytokine engineering. His work is characterized by a commitment to innovation and the application of scientific principles to solve complex medical challenges.

Collaborations

Oren has collaborated with notable colleagues, including Nigel Killeen and Benedikt K Vollrath. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Oren Beske is a pioneering inventor whose work in engineered cytokines holds promise for future medical applications. His contributions to the field of cytokine engineering are significant and may lead to new treatments for various diseases.